Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM
- PMID: 32035737
- DOI: 10.1016/j.tem.2020.01.001
Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM
Abstract
Diabetes mellitus (DM) is a devastating metabolic disease. Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. In this article, we discuss major advantages of WJ-MSCs and challenges facing their clinical utility in DM.
Keywords: Wharton’s jelly; diabetes mellitus; insulin-producing cells; mesenchymal stem cells.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
